Four Individuals Named Ovarian Cancer Heroes at Inaugural Event
March 24th 2018At the inaugural Ovarian Cancer Heroes gala, held in New Orleans ahead of the 49th Society of Gynecologic Oncology Annual Meeting on Women’s Cancers, four individuals — a physician, nurse navigator and two patient-turned-advocates — were awarded for the contributions they have made to increase awareness and advance research and education for ovarian cancer.
Read More
Oropharyngeal Cancer Risks Include Number of Sexual Partners, Smoking
December 9th 2017The incidence of human papillomavirus-related oropharyngeal cancer (HPV-OPC) is on the rise. Researchers at Johns Hopkins University assessed survey data to determine whether the risk among the general population is rising as well. Results show that for most people, the risk remains low.
Read More
How Many Weeks of Adjuvant Herceptin Is Optimal for People with HER2-Positive Breast Cancer?
December 8th 2017A phase 3 clinical trial pitted a nine-week treatment of adjuvant Herceptin against the regimen of a full year of treatment for patients with HER2-positive breast cancer. Results show that the standard treatment of one year is still optimal.
Read More
Controversial Breast Cancer Treatment Strategy May Protect Ovarian Function, Preserve Fertility
December 7th 2017A reveiw of five clinical trial findings suggests that gonadotropin-releasing hormone analog has the potential to preserve ovarian function and fertility in premenopausal breast cancer patients.
Read More
Kisqali Extends Progression-Free Survival for Premenopausal Breast Cancer Subsets
December 7th 2017New research demonstrates that a CDK4/6 inhibitor, used in combination with standard endocrine therapy with temporary ovarian suppression significantly improves progression-free survival in younger patients who currently have few treatment options.
Read More
Alternative Chemotherapy Dosing Strategies Improve Breast Cancer Outcomes
December 6th 2017For women with early-stage breast cancer who are receiving chemotherapy, shortening the time between treatment cycles or administering the agents sequentially may reduce disease recurrence and mortality compared with standard chemotherapy regimens.
Read More
Immunotherapy Combination Sparks a Response in Melanoma Brain Metastases
October 23rd 2017The combination of the immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) sparked a response in nearly half of asymptomatic patients with melanoma brain metastases who had not received prior local therapy to the brain.
Read More
Intralesional Combinations Are Promising in Melanoma
October 19th 2017Intralesional therapies – those delivered directly to the tumor site – used in conjunction with checkpoint inhibitors have shown improvements to the treatment of people with melanoma, says Robert Andtbacka, M.D., in a presentation at the 2017 World Congress of Melanoma.
Read More
Don't Let Ovarian Cancer Take Away Your Sex Life
July 10th 2017Many patients with cancer don't hesitate when discussing side effects like fatigue, nausea and neuropathy with their health care provider; however, there is often silence when it boils down to the sexual side effects of their treatment.
Read More
David Gershenson on Challenges to Advancing Treatment for Rare Ovarian Cancers
July 10th 2017David Gershenson, M.D., of MD Anderson Cancer Center, explains the difficulty of advancing treatment of rare ovarian cancers: malignant ovarian germ cell tumors, sex cord stromal tumors, and types of epithelial tumors such as ovarian clear cell carcinoma, ovarian low-grade serous carcinoma, and mucinous tumors.
Watch
Clinical Trials Are the Way Forward for Ovarian Cancer, but They Need Advocates at Every Level
July 9th 2017For women with ovarian cancer, the message is clear: participating in clinical trials, even early-phase ones, offers the best hope for better treatments, but efforts are urgently needed at every level to ensure that more of these research opportunities are available.
Read More
Sarah Sciortino on Fertility and Sexuality in Younger Patients with Ovarian Cancer
July 9th 2017Sarah Sciortino, MSW, LSW, Oncology Psychosocial Support Services Program Coordinator at University of Chicago Hospital, discusses the unique concerns that younger patients with ovarian cancer can face.
Watch
The Road Ahead for Ovarian Cancer
July 9th 2017Opening the 20th Annual Ovarian Cancer National Conference in Chicago, John Moroney, M.D., underscored the challenges that remain in the early detection and treatment of ovarian cancer, but also the tremendous hope that resides in robust clinical trial research.
Read More